Krishna S.

Krishna S. has a diverse range of work experience spanning various industries and roles. Currently, they hold the position of Vice President and Head of Non-clinical and Translational Science at Seelos Therapeutics, Inc. Prior to this, they were a Senior Director and Head of Pre-Clinical Research at Alcyone Therapeutics Inc. from 2018 to 2021. Additionally, Krishna S. has experience as a sMBA trained professional at Morning Brew, a Clinical Research Manager at Virginia Commonwealth University, and a Project Consultant at PreScouter, Inc. They also worked as a Post-doctoral Research Scientist at the Hussman Institute for Autism, a Postdoctoral Researcher at Baylor College of Medicine, and a CNBC Graduate student fellow at Carnegie Mellon University. Krishna S. began their career as a Research fellow at the Centre for Cellular and Molecular Biology.

Krishna S. obtained a Bachelor of Technology (B.Tech.) degree in Biotechnology from Anna University between 2003 and 2007. They then pursued a Doctor of Philosophy (PhD) degree in Neurobiology and Neurosciences from the University of Pittsburgh School of Medicine from 2007 to 2013. In addition, Krishna has received certifications in Learn Emotional Intelligence, the Key Determiner of Success, Microsoft Project 2016 Essential Training, Six Sigma: Green Belt, and Project Management Simplified. The specific months of obtaining these certifications are not provided.